Chlorhexidine Gluconate (CHG) Wipes Market
By Type;
Chlorhexidine Gluconate (CHG) Bath Wipes and Chlorhexidine Gluconate (CHG) Alcohol-Based WipesBy Application;
Surgical Site Infections, Central Line-Associated Bloodstream Infections, Catheter-Associated Urinary Tract Infections, and OthersBy Distribution Channel;
Pharmacies, Supermarkets, Specialty Stores, and Direct SalesBy End User;
Hospitals, Clinics, Ambulatory Surgical Centers, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Chlorhexidine Gluconate (CHG) Wipes Market Overview
Chlorhexidine Gluconate (CHG) Wipes Market (USD Million)
Chlorhexidine Gluconate (CHG) Wipes Market was valued at USD 14,562.64 million in the year 2024. The size of this market is expected to increase to USD 19,685.37 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.4%.
Chlorhexidine Gluconate (CHG) Wipes Market
*Market size in USD million
CAGR 4.4 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 4.4 % |
Market Size (2024) | USD 14,562.64 Million |
Market Size (2031) | USD 19,685.37 Million |
Market Concentration | High |
Report Pages | 377 |
Major Players
- Becton Dickinson and Company
- 3M
- Cardinal Health
- GAMA Healthcare Ltd
- Carenow Medical Pvt. Ltd.
- PDI Limited
- Lernapharm Inc.
- Pal International
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Chlorhexidine Gluconate (CHG) Wipes Market
Fragmented - Highly competitive market without dominant players
The Chlorhexidine Gluconate (CHG) Wipes Market is expanding rapidly as infection control and hygiene become top priorities in healthcare systems. More than 60% of hospitals rely on CHG wipes for reducing healthcare-associated infections, reinforcing their critical role in patient safety protocols. The simple yet effective design of CHG wipes continues to boost their demand across clinical practices.
Rising Usage in Surgical Preparation
One of the strongest growth drivers is the increasing application of CHG wipes in preoperative skin preparation. Currently, around 45% of surgical procedures use these wipes to minimize infection risks, making them a preferred alternative to conventional antiseptics. Their quick application and reliable performance enhance their acceptance among medical professionals.
Growing Adoption Across Care Environments
The usage of CHG wipes extends beyond hospitals into ambulatory centers and home healthcare. Over 35% of patients receiving home treatment now use antiseptic wipes for infection prevention. This trend reflects how infection awareness and convenience are shaping consumer preferences outside of hospital settings.
Innovation Strengthening Market Growth
Advancements in formulation technology are improving both the efficacy and skin tolerance of CHG wipes. Nearly 50% of newly launched products feature dual formulations, combining CHG with alcohol for stronger antimicrobial action. These innovations are creating competitive differentiation and expanding clinical adoption.
Chlorhexidine Gluconate (CHG) Wipes Market Recent Developments
-
In 2023, The companies belonging to the North American market are largely focusing on variants of CHG cloth that will benefit a larger audience and help in staggering a global demand by the end of the forecast year
-
In 2020 The European nations are largely focusing on the development of the CHG market by focusing on product development through company mergers and acquisition
Chlorhexidine Gluconate (CHG) Wipes Market Segment Analysis
In this report, the Chlorhexidine Gluconate (CHG) Wipes Market has been segmented by Type, Application, Distribution Channel, End User and Geography.
Chlorhexidine Gluconate (CHG) Wipes Market, Segmentation By Type
The Chlorhexidine Gluconate (CHG) Wipes Market has been segmented by Type into Chlorhexidine Gluconate (CHG) Bath Wipes and Chlorhexidine Gluconate (CHG) Alcohol-Based Wipes.
Chlorhexidine Gluconate (CHG) Bath Wipes
CHG bath wipes dominate the market, holding nearly 60–62% of the total share. They are extensively used in preoperative skin preparation and routine patient hygiene to reduce infection risks. Their growing adoption in hospitals and long-term care facilities is driven by rising awareness of healthcare-associated infections (HAIs). Demand continues to grow at an annual rate of about 10–12%.
Chlorhexidine Gluconate (CHG) Alcohol-Based Wipes
CHG alcohol-based wipes account for approximately 38–40% of the market. They provide rapid antimicrobial action, making them ideal for catheter site care, injection preparation, and quick disinfection procedures. Their convenience and effectiveness have increased adoption in outpatient clinics and emergency settings. This segment is expected to grow steadily at around 8–10% annually, supported by rising infection-control protocols.
Chlorhexidine Gluconate (CHG) Wipes Market, Segmentation By Application
The Chlorhexidine Gluconate (CHG) Wipes Market has been segmented by Application into Surgical Site Infections, Central Line-Associated Bloodstream Infections, Catheter-Associated Urinary Tract Infections and Others.
Surgical Site Infections
Surgical site infections (SSIs) are the leading application area, accounting for nearly 42–44% of the CHG wipes market. These wipes are widely used in preoperative skin preparation to minimize microbial contamination and reduce infection risks. Growing adoption in hospitals and surgical centers continues to drive strong demand in this segment.
Central Line-Associated Bloodstream Infections
Central line-associated bloodstream infections (CLABSIs) represent about 28–30% of market share. CHG wipes are preferred for catheter site cleaning due to their proven ability to reduce bloodstream infection risks. The segment is expanding steadily as healthcare institutions adopt stricter infection-control protocols and quality care standards.
Catheter-Associated Urinary Tract Infections
Catheter-associated urinary tract infections (CAUTIs) hold nearly 18–20% of the market. CHG wipes help reduce bacterial colonization and infection risks in patients with long-term catheter use. Rising cases of hospital-acquired infections and demand for cost-effective prevention strategies are fueling segment growth.
Others
The others category, including general disinfection and outpatient procedures, contributes about 8–10% of the market. These wipes are used in emergency care, routine patient cleaning, and minor wound management. Though smaller in share, this segment is growing steadily due to increasing emphasis on preventive infection control practices across healthcare settings.
Chlorhexidine Gluconate (CHG) Wipes Market, Segmentation By Distribution Channel
The Chlorhexidine Gluconate (CHG) Wipes Market has been segmented by Distribution Channel into Pharmacies, Supermarkets, Specialty Stores and Direct Sales.
Pharmacies
Pharmacies dominate the CHG wipes market, accounting for nearly 40–42% of overall distribution. They serve as the most trusted channel for infection-prevention products, supported by pharmacist recommendations and ease of accessibility. Rising demand for hospital-grade disinfectant wipes in retail settings continues to strengthen this segment.
Supermarkets
Supermarkets contribute around 25–27% of the market, benefiting from high consumer footfall and availability of multipurpose hygiene products. Their ability to offer bulk packaging and promotional discounts has boosted sales. The growing trend of one-stop healthcare shopping further enhances the segment’s expansion.
Specialty Stores
Specialty stores hold nearly 18–20% of the CHG wipes market, catering to customers seeking premium healthcare and hygiene products. These stores often focus on branded medical supplies and niche infection-control solutions. Their importance is increasing with the rise of awareness-driven consumer buying behavior.
Direct Sales
Direct sales account for approximately 12–14% of the distribution channel. This includes hospital supply contracts and institutional sales, ensuring bulk purchases and consistent demand. Direct sales remain essential for meeting the needs of large healthcare facilities and government-driven infection prevention programs.
Chlorhexidine Gluconate (CHG) Wipes Market, Segmentation By End User
The Chlorhexidine Gluconate (CHG) Wipes Market has been segmented by End User into Hospitals, Clinics, Ambulatory Surgical Centers and Others.
Hospitals
Hospitals are the primary end users of CHG wipes, holding nearly 45–47% of the total market. These wipes are extensively used for preoperative skin preparation, infection control, and patient hygiene. The rising incidence of hospital-acquired infections (HAIs) and strict adherence to sterilization protocols continue to drive strong demand in this segment.
Clinics
Clinics account for around 22–24% of the market, driven by their role in providing outpatient care and minor surgical procedures. CHG wipes are widely used for wound cleaning, catheter site care, and basic infection prevention. Growing awareness of cost-effective hygiene solutions in primary care is boosting their adoption in clinics.
Ambulatory Surgical Centers
Ambulatory surgical centers (ASCs) represent nearly 18–20% of the market. These facilities rely heavily on CHG wipes for pre-surgical skin cleansing and reducing surgical site infections (SSIs). The increasing shift toward same-day surgeries and minimally invasive procedures is fueling demand within this segment at a steady growth rate.
Others
The others category, which includes long-term care facilities, emergency centers, and home healthcare, contributes about 10–12% of the market. CHG wipes in this segment are primarily used for routine hygiene and infection prevention among vulnerable patient groups. Expanding awareness of preventive care is expected to support continued adoption in this category.
Chlorhexidine Gluconate (CHG) Wipes Market, Segmentation By Geography
In this report, the Chlorhexidine Gluconate (CHG) Wipes Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Regions and Countries Analyzed in this Report
Chlorhexidine Gluconate (CHG) Wipes Market Share (%), By Geographical Region
North America
North America leads the CHG wipes market, accounting for nearly 38–40% of global revenue. High adoption in hospitals and surgical centers, combined with strong emphasis on infection prevention protocols, drives growth. The presence of major healthcare providers and stringent regulatory standards further strengthen the region’s dominance.
Europe
Europe contributes around 27–29% of the market, supported by rising healthcare-associated infection (HAI) awareness and government-led initiatives for patient safety. Countries like Germany, the U.K., and France are leading adopters, with consistent demand from hospitals and clinics. Growing preference for preoperative hygiene solutions fuels continued market expansion.
Asia Pacific
Asia Pacific holds about 20–22% of the market and is the fastest-growing region. Increasing incidence of chronic diseases, rapid expansion of healthcare infrastructure, and greater awareness of infection control are driving adoption. Countries such as China, India, and Japan are at the forefront of regional growth, supported by higher investments in preventive care.
Middle East & Africa
Middle East & Africa collectively account for nearly 7–8% of the global market. Demand is driven by growing investments in hospital facilities and efforts to reduce hospital-acquired infections. Although adoption is comparatively lower, increasing penetration of specialized hygiene products is supporting gradual growth in this region.
Latin America
Latin America represents approximately 6–7% of the market, with Brazil and Mexico as key contributors. Expansion of public health programs and growing emphasis on infection prevention are driving sales. The rising use of cost-effective hygiene solutions in hospitals and clinics is expected to fuel steady demand across the region.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Chlorhexidine Gluconate (CHG) Wipes Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Rising Awareness of Antimicrobial Resistance
- Surge in Surgical Procedures
-
Increasing Emphasis on Infection Prevention- Healthcare facilities worldwide are increasingly prioritizing infection control measures to mitigate the risk of healthcare-associated infections (HAIs) and improve patient safety outcomes. CHG wipes, infused with the antimicrobial agent chlorhexidine gluconate, offer an effective solution for disinfecting skin and surfaces, thereby reducing the transmission of pathogens and minimizing the risk of HAIs.
Healthcare-associated infections pose a significant threat to patient safety and can lead to prolonged hospital stays, increased healthcare costs, and even mortality. In response, healthcare facilities are implementing stringent hygiene protocols and antimicrobial stewardship initiatives to prevent infections and protect vulnerable patient populations. CHG wipes play a crucial role in these infection prevention strategies, providing healthcare professionals with a convenient and reliable tool for disinfection in various clinical settings. Moreover, the emergence of antimicrobial resistance (AMR) further underscores the importance of effective infection prevention measures. CHG wipes offer a broad-spectrum antimicrobial activity with minimal risk of resistance development, making them valuable assets in combating AMR and preserving the effectiveness of antibiotics. As healthcare systems worldwide grapple with the challenge of AMR, the demand for CHG wipes is expected to escalate, driving market growth and adoption. Additionally, regulatory bodies and healthcare organizations are increasingly emphasizing the importance of infection prevention and control practices, mandating compliance with strict hygiene standards and guidelines. This regulatory environment further amplifies the demand for CHG wipes as healthcare facilities strive to adhere to stringent infection control protocols and ensure compliance with regulatory requirements.
Restraints
- Potential Side Effects
- Cost Considerations
-
Limited Awareness and Education- One of the primary challenges is the lack of awareness among healthcare professionals and consumers regarding the benefits and proper use of CHG wipes for infection prevention. Many healthcare providers may not be fully informed about the efficacy of CHG wipes in reducing healthcare-associated infections (HAIs) and may opt for alternative disinfection methods or products. Similarly, patients and caregivers may be unaware of the importance of CHG wipes in maintaining hygiene and preventing infections, leading to underutilization of these products. Moreover, limited education and training initiatives further exacerbate the problem, as healthcare professionals may not receive adequate instruction on the correct application and usage of CHG wipes. Without proper education, there is a risk of improper use of CHG wipes, which can compromise their effectiveness and contribute to suboptimal infection control practices. Additionally, misconceptions or misinformation about CHG wipes may lead to hesitancy or reluctance among healthcare professionals and consumers to incorporate these products into their infection prevention protocols.
Another aspect of limited awareness and education is the lack of standardized guidelines or protocols for the use of CHG wipes in different healthcare settings. Without clear guidance from regulatory authorities or professional organizations, healthcare facilities may struggle to implement consistent and evidence-based practices regarding the use of CHG wipes. This lack of standardization can lead to variability in practice and hinder widespread adoption of CHG wipes across healthcare institutions.
Opportunities
- Expansion of Healthcare Infrastructure
-
Expansion into Non-Healthcare Sectors- Traditionally, CHG wipes have been primarily utilized in healthcare settings, such as hospitals, clinics, and surgical centers, due to their effectiveness in reducing microbial contamination and preventing healthcare-associated infections (HAIs). However, the potential for CHG wipes extends beyond healthcare, opening doors to new market segments and revenue streams. One key area of opportunity lies in the hospitality industry, particularly in hotels, resorts, and cruise ships. With a growing emphasis on cleanliness and sanitation in the wake of global health concerns, there is an increased demand for disinfecting wipes in hospitality settings to reassure guests of their safety and well-being. CHG wipes offer an effective solution for maintaining hygienic environments in guest rooms, public spaces, and food service areas, thereby enhancing the overall guest experience and satisfaction.
Another promising avenue for expansion is in the manufacturing sector, where stringent hygiene standards are essential for ensuring product quality and safety. Industries such as food processing, pharmaceuticals, and electronics manufacturing require rigorous sanitation protocols to prevent contamination and comply with regulatory requirements. CHG wipes can be utilized for surface disinfection in cleanrooms, production facilities, and equipment maintenance, helping companies uphold cleanliness standards and minimize the risk of product contamination.
Competitive Landscape Analysis
Key players in Global Chlorhexidine Gluconate (CHG) Wipes Market include:
- Becton Dickinson and Company
- 3M
- Cardinal Health
- GAMA Healthcare Ltd
- Carenow Medical Pvt. Ltd.
- PDI Limited
- Lernapharm Inc.
- Pal International
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By End User
- Market Snapshot, By Region
- Chlorhexidine Gluconate (CHG) Wipes Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Rising Awareness of Antimicrobial Resistance
-
Surge in Surgical Procedures
-
Increasing Emphasis on Infection Prevention
-
- Restraints
-
Potential Side Effects
-
Cost Considerations
-
Limited Awareness and Education
-
- Opportunities
-
Expansion of Healthcare Infrastructure
-
Expansion into Non-Healthcare Sectors
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Chlorhexidine Gluconate (CHG) Wipes Market, By Type, 2021 - 2031 (USD Million)
- Chlorhexidine Gluconate (CHG) Bath Wipes
- Chlorhexidine Gluconate (CHG) Alcohol-Based Wipes
- Chlorhexidine Gluconate (CHG) Wipes Market, By Application, 2021 - 2031 (USD Million)
- Surgical Site Infections
- Central Line-Associated Bloodstream Infections
- Catheter-Associated Urinary Tract Infections
- Others
- Chlorhexidine Gluconate (CHG) Wipes Market, By Distribution Channel, 2021 - 2031 (USD Million)
- Pharmacies
- Supermarkets
- Specialty Stores
- Direct Sales
-
Chlorhexidine Gluconate (CHG) Wipes Market, By End User, 2021 - 2031 (USD Million)
-
Hospitals
-
Clinics
-
Ambulatory Surgical Centers
-
Others
-
- Chlorhexidine Gluconate (CHG) Wipes Market, By Geography, 2021 - 2031 (USD Million)
-
North America
-
United States
-
Canada
-
-
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Nordic
-
Benelux
-
Rest of Europe
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Australia & New Zealand
-
South Korea
-
ASEAN (Association of South East Asian Countries)
-
Rest of Asia Pacific
-
-
Middle East & Africa
-
GCC
-
Israel
-
South Africa
-
Rest of Middle East & Africa
-
-
Latin America
-
Brazil
-
Mexico
-
Argentina
-
Rest of Latin America
-
-
- Chlorhexidine Gluconate (CHG) Wipes Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
-
Becton Dickinson and Company
-
3M
-
Cardinal Health
-
GAMA Healthcare Ltd
-
Carenow Medical Pvt. Ltd.
-
PDI Limited
-
Lernapharm Inc.
-
Pal International
-
- Company Profiles
- Analyst Views
- Future Outlook of the Market